immunity therapy
Showing 51 - 75 of >10,000
MDD Trial in Erlangen (TaKeTiNa music therapy)
Recruiting
- Major Depressive Disorder
- TaKeTiNa music therapy
-
Erlangen, Bavaria, GermanyUniversity Hospital of Erlangen - Psychiatric Clinic
Mar 21, 2023
COVID-19 Trial in Vandœuvre-lès-Nancy (Generation of a biobank allowing the cryopreservation of leucocytes from COVID19
Not yet recruiting
- COVID-19
- Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors
-
Vandœuvre-lès-Nancy, Lorraine, FranceCHRU-Nancy - Hopitaux de Brabois - Batiment Philippe Canton
Aug 17, 2022
HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)
Recruiting
- HNSCC
- +4 more
- blood draws
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Kidney Stone Trial in Birmingham (Low Oxalate Diet, High Oxalate Diet)
Recruiting
- Kidney Stone
- Low Oxalate Diet
- High Oxalate Diet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Mar 23, 2022
Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)
Not yet recruiting
- Breast Cancer Female
- Triple Negative Breast Cancer
- quercetin, EGCG, metformin , zinc
- (no location specified)
Dec 23, 2022
Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)
Withdrawn
- Metastatic Melanoma
- +5 more
- single arm
- (no location specified)
Dec 20, 2022
Cirrhosis Due to Hepatitis B Trial in Wuhan (UC-MSCs, Saline solution)
Recruiting
- Cirrhosis Due to Hepatitis B
- UC-MSCs
- Saline solution
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Aug 18, 2022
Healthy Trial in Herlev (Exercise)
Recruiting
- Healthy
- Exercise
-
Herlev, DenmarkHerlev Hospital
Apr 24, 2023
Chronic Kidney Diseases Trial in Taoyuan (Cyclic aerobic and resistance training)
Recruiting
- Chronic Kidney Diseases
- Cyclic aerobic and resistance training
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 12, 2022
Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)
Recruiting
- Neoadjuvant Chemoradiation Therapy
- +3 more
- xintilimab injection
- Control
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery in Changhai Hospital
Aug 5, 2022
Blood and Urine on Renal and Patient Prognosis in Acute Kidney
Recruiting
- Acute Kidney Injury
-
Kirikkale, Yahsihan, TurkeyKirikkale University
Feb 9, 2023
Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)
Not yet recruiting
- Nephrotic Syndrome
- Rituximab Biosimilar ABP 798
- Daratumumab
-
Genova, ItalyIRCCS G. Gaslini
Jan 19, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
Not yet recruiting
- Ulcerative Colitis
- (no location specified)
Nov 20, 2023
Cancer, Covid19, Immunity Trial in Hamburg
Recruiting
- Cancer
- +2 more
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Mar 18, 2021
Normal Subjects and Disorders of Immune System and Cancer
Recruiting
- T-cell Lymphoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 31, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
-
Vancouver, British Columbia, CanadaSt. Paul's Sinus Centre
Oct 24, 2023
Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)
Recruiting
- Recurrent Glioblastoma
- Combined stereotactic radiosurgery and enhanced immunotherapy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Nov 16, 2021
Post-COVID19 Condition Trial in Badalona (Plasma Exchange Procedure, Sham Plasma Exchange Procedure)
Recruiting
- Post-COVID19 Condition
- Plasma Exchange Procedure
- Sham Plasma Exchange Procedure
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Oct 3, 2022
Aging, Vaccine Response Impaired Trial in San Antonio (Metformin, Placebo)
Active, not recruiting
- Aging
- Vaccine Response Impaired
- Metformin
- Placebo
-
San Antonio, TexasUT Health San Antonio
Feb 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein
Completed
- HIV Infections
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
- +2 more
-
Birmingham, Alabama
- +5 more
Oct 27, 2021
Allergic Rhinitis Trial in Anshan (Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).)
Not yet recruiting
- Allergic Rhinitis
- Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).
-
Anshan, Guizhou, ChinaGuangjun Tang
Oct 5, 2022
Malignant Hemopathy Trial in Saint-Etienne (Blood samples)
Not yet recruiting
- Malignant Hemopathy
- Blood samples
-
Saint-Etienne, FranceCHU de Saint-Etienne
Feb 7, 2022